Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

600329

Rang în acțiuni #4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Preț acțiune
$6.17
Capitalizare de piață
$3.52B
Schimbare (1 zi)
-0.05%
Schimbare (1 an)
-1.86%
Țară
CN
Tranzacționează Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)

Categorie

Healthcare
Marja operațională pentru Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Marja operațională la October 2026 TTM: 18.33%
Conform celor mai recente rapoarte financiare și prețului acțiunilor Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, marja operațională curentă (TTM) este 18.33%. La finalul anului 2024, compania avea o marjă operațională de 35.13%.
Istoricul marjei operaționale pentru Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited din 2001 până în 2026
Marja operațională la sfârșitul fiecărui an
An Marja Operațională Schimbă
2026 (TTM) 18.33% -63.80%
2025 50.63% 44.12%
2024 35.13% 163.34%
2023 13.34% 12.29%
2022 11.88% -5.34%
2021 12.55% 5.55%
2020 11.89% 9.59%
2019 10.85% 7.53%
2018 10.09% 9.08%
2017 9.25% 32.33%
2016 6.99% -0.85%
2015 7.05% 20.93%
2014 5.83% -13.50%
2013 6.74% 24.58%
2012 5.41% -12.46%
2011 6.18% -10.82%
2010 6.93% -4.55%
2009 7.26% 83.33%
2008 3.96% -167.69%
2007 -5.85% -65.20%
2006 -16.81% -1,112.65%
2005 1.66% -47.30%
2004 3.15% -30.46%
2003 4.53% -18.23%
2002 5.54% 4.92%
2001 5.28% 0.00%
Marja operațională pentru companii similare sau concurente
Companie Marja Operațională Diferență în marja operațională Țara
0.00% -
DE
0.00% -
DE
10.52% -99.43%
JP
0.00% -
CH
22.93% -98.75%
IN
Ce este marja operațională a unei companii?
Marja operațională este un indicator esențial pentru evaluarea profitabilității unei companii. Marjele operaționale mai mari sunt de obicei mai bune, deoarece arată că o companie poate vinde produsele sau serviciile sale la prețuri mult mai mari decât costurile de producție. Marja operațională se calculează împărțind profitul companiei la venitul său.